Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-058254·Nant Capital, LLC
Schedule 13D ownership disclosure
PANBELA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 69833W404
Event date: 2025-04-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nant Capital, LLCReported CIK 0001675758
Shares: 32,432,432 · Class: 86.98%
- Patrick Soon-ShiongReported CIK 0001189020
Shares: 32,432,432 · Class: 86.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-058254
- Form type
- SCHEDULE 13D/A
- Filer
- Nant Capital, LLC
- CIK
- CIK 1675758
- Filed
- Apr 24, 2025
- Reporting period
- Apr 22, 2025
- Description
- Schedule 13D beneficial ownership